These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 722302)

  • 21. Continuation treatment of delusional depression in older adults.
    Meyers BS; Klimstra SA; Gabriele M; Hamilton M; Kakuma T; Tirumalasetti F; Alexopoulos GS
    Am J Geriatr Psychiatry; 2001; 9(4):415-22. PubMed ID: 11739068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mixed mania associated with tricyclic antidepressant therapy in prepubertal delusional depression: three cases.
    Strober M
    J Child Adolesc Psychopharmacol; 1998; 8(3):181-5. PubMed ID: 9853692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of tricyclic antidepressants on individual symptoms.
    Welner A; Welner Z; Robins E
    J Clin Psychiatry; 1980 Sep; 41(9):306-9. PubMed ID: 7410324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case report of successful treatment of dysmorphophobia with tranylcypromine.
    Jenike MA
    Am J Psychiatry; 1984 Nov; 141(11):1463-4. PubMed ID: 6149701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment strategy in depression. II. MAO inhibitors in depression resistant to cyclic antidepressants: two controlled crossover studies with tranylcypromine versus L-5-hydroxytryptophan and nomifensine.
    Nolen WA; van de Putte JJ; Dijken WA; Kamp JS; Blansjaar BA; Kramer HJ; Haffmans J
    Acta Psychiatr Scand; 1988 Dec; 78(6):676-83. PubMed ID: 3146891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
    McGrath PJ; Stewart JW; Fava M; Trivedi MH; Wisniewski SR; Nierenberg AA; Thase ME; Davis L; Biggs MM; Shores-Wilson K; Luther JF; Niederehe G; Warden D; Rush AJ
    Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of the circadian variation of platelet [3H]imipramine binding in delusional compared with non-delusional endogenously depressed patients.
    Vallejo J; Rosel P; Arranz B; Urretavizcaya M; Menchón JM; Contreras F; Navarro MA
    J Affect Disord; 2002 Oct; 72(1):95-101. PubMed ID: 12204323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tranylcypromine treatment of major depression.
    Liebowitz MR
    J Clin Psychiatry; 1987 Jul; 48(7):303. PubMed ID: 3597337
    [No Abstract]   [Full Text] [Related]  

  • 29. Antidepressant efficacy of tranylcypromine isomers: a controlled study.
    Moises HW; Beckmann H
    J Neural Transm; 1981; 50(2-4):185-92. PubMed ID: 7017068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet 5-HT uptake in delusional and nondelusional depressions.
    Healy D; O'Halloran A; Carney PA; Leonard BE
    J Affect Disord; 1986; 10(3):233-9. PubMed ID: 2943778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lithium-TCA combination treatment of psychotic depression: comparison with TCA-neuroleptic treatment.
    Ebert D
    J Clin Psychopharmacol; 1997 Apr; 17(2):129-30. PubMed ID: 10950483
    [No Abstract]   [Full Text] [Related]  

  • 32. Delusional unipolar depression: description and drug response.
    Nelson JC; Bowers MB
    Arch Gen Psychiatry; 1978 Nov; 35(11):1321-8. PubMed ID: 30427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combining tricyclic and monoamine oxidase inhibitor antidepressants.
    Spiker DG; Pugh DD
    Arch Gen Psychiatry; 1976 Jul; 33(7):828-30. PubMed ID: 942286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
    Meco G; Bernardi S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High dose tranylcypromine therapy for refractory depression.
    Amsterdam JD; Berwish NJ
    Pharmacopsychiatry; 1989 Jan; 22(1):21-5. PubMed ID: 2710808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tranylcypromine (Parnate)--a study of 1000 patients with severe agitated depressions.
    Lesse S
    Am J Psychother; 1978 Apr; 32(2):220-42. PubMed ID: 677352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychotic depression: the common therapeutic principle.
    Hofstatter L; Girgis M
    South Med J; 1980 Jul; 73(7):870-2. PubMed ID: 6104359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tranylcypromine Plus Amitriptyline for Electroconvulsive Therapy-Resistant Depression: A Long-Term Study.
    Ferreira-Garcia R; da Rocha Freire RC; Appolinário JC; Levitan MN; Halkjær-Lassen RD; Bueno JR; Nardi AE
    J Clin Psychopharmacol; 2018 Oct; 38(5):502-504. PubMed ID: 30106881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of Tranylcypromine and Mirtazapine in Difficult-to-Treat Depression.
    Kavakbasi E; Baune BT
    J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):585-588. PubMed ID: 34369903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.